Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Indiana City Sues Over Failed Pharmaceutical Facility

By Pharmaceutical Processing | June 14, 2013

GREENWOOD, Ind. (AP) — A suburban Indianapolis city has filed a foreclosure lawsuit against a pharmaceutical company that failed to open after receiving $8.4 million in loans and other assistance from the city.

Greenwood officials had tried for months to help with talks involving possible investors in hopes of saving Elona Biotechnologies before deciding to file the lawsuit, Mayor Mark Myers said.

“There just wasn’t any progress,” Myers told the Daily Journal (http://bit.ly/175rafa ).

City attorney Krista Taggart said the lawsuit asks for a Johnson County judge to appoint a receiver who would try to sell Elona’s unfinished facility and equipment for making insulin.

Greenwood officials three years ago approved the project incentives, including a $6 million construction loan for 50,000-square-foot plant in a business park east of the city just south of Indianapolis. Elona said then it expected to employ some 70 workers and spend more than $25 million on a planned expansion.

The company founders didn’t return the Daily Journal’s calls seeking comment. The company’s phone number was disconnected when called by The Associated Press.

A hearing on the lawsuit is scheduled for Tuesday.

Greenwood officials maintain the company owes the city nearly $9.5 million, an amount that includes the interest that’s been accruing. Myers said the city hopes to recoup at least $3 million.

City Council member Mike Campbell said the loss of the money loaned to Elona won’t prevent the city from carrying out planned projects, including construction of a new Interstate 65 interchange. But the loss could force the city to scale back future plans and review other incentive packages more closely, he said.

___

Information from: Daily Journal, http://www.dailyjournal.net

 

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE